✦ LIBER ✦

300 PHASE 1B DOSE-ESCALATION STUDY OF SD-101, A NOVEL THERAPEUTIC TLR-9 AGONIST, IN TREATMENT-NAIVE CHRONIC HEPATITIS C PATIENTS

✍ Scribed by J. Cianciara; J.T. Martin; M.C. Spellman

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

32 A PHASE 1, MULTI-CENTER, RANDOMIZED,

✍ A. Muir; R. Ghalib; E. Lawitz; K. Patel; M. Rodriguez-Torres; A. Sheikh; S. Sapp 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Daily dose of interferon alpha-2b and ri

✍ GianPiero Benetti; Mauro Borzio; Giuliano Ramella; Giorgio Bellati; Silvia Fargi 📂 Article 📅 2006 🏛 Springer Milan 🌐 English ⚖ 98 KB

1163 A PHASE 2A STUDY OF BMS-791325, AN

✍ Tatum, H.; Thuluvath, P.; Lawitz, E.; Martorell, C.T.; Demicco, M.; Cohen, S.; R 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Treatment of chronic hepatitis C patient

✍ Nicole Forestier; Dominique Larrey; Dominique Guyader; Patrick Marcellin; Régine 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 651 KB